Jorge Martín-Pérez

Dr. Jorge Martín-Pérez

Instituto de Investigaciones Biomédicas A. Sols (CSIC/UAM)
+3
orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1982 in Cell
Verified
Journal Article
Closed access
GTG Thomas
G Thomas
Jorge Martín-PérezJorge Martín-Pérez
Jorge Martín-Pérez
MSM Siegmann
M Siegmann
AOA M Otto
A M Otto

12 April 2004 in Oncogene
Verified
Journal Article
Closed access
DSDavid Sarrió
David Sarrió
BPBelén Pérez-Mies
Belén Pérez-Mies
David HardissonDavid Hardisson
David Hardisson
GMGema Moreno-Bueno
Gema Moreno-Bueno
ASAsunción Suárez
Asunción Suárez
JPJosé Palacios
José Palacios

1 November 2003 in Molecular Endocrinology
Verified
Journal Article
Closed access
JAJuan J. Acosta
Juan J. Acosta
RMRaúl M. MuñoZ
Raúl M. MuñoZ
LGLorena GonzálEz
Lorena GonzálEz
ASAlicia Subtil-RodrígUez
Alicia Subtil-RodrígUez
MDMaría Aurora DomínGuez-CácEres
María Aurora DomínGuez-CácEres
Jorge Martín-PérezJorge Martín-Pérez
Jorge Martín-Pérez
Prolactin (PRL) stimulates breast cancer cell proliferation; however, the involvement of PRL-activated signaling molecules in cell proliferation is not fully established. Here we studied the role of c-Src on PRL-stimulated proliferation of T47D and MCF7 breast cancer cells. We initially observed that PRL-dependent activation of focal adhesion kinase (Fak), Erk1/2, and cell proliferation was mediated by c-Src in T47D cells, because expression of a dominant-negative form of c-Src (SrcDM, K295A/Y527F) blocked the PRL-dependent effects. The Src inhibitor PP1 abrogated PRL-dependent in vivo activation of Fak, Erk1/2, p70S6K, and Akt and the proliferation of T47D and MCF7 cells; Janus kinase 2 (Jak2) activation was not affected. However, in vitro, Fak and Jak2 kinases were not directly inhibited by PP1, demonstrating the effect of PP1 on c-Src kinase as an upstream activator of Fak. Expression of Fak mutant Y397F abrogated PRL-dependent activation of Fak, Erk1/2, and thymidine incorporation, but had no effect on p70S6K and Akt kinases. MAPK kinase 1/2 (Mek1/2) inhibitor PD184352 blocked PRL-induced stimulation of Erk1/2 and cell proliferation; however, p70S6K and Akt activation were unaffected. The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 abolished cell proliferation and activation of p70S6K and Akt; however, PRL-dependent activation of Erk1/2 was not modified. Moreover, we show that both c-Src/PI3K and c-Src/Fak/Erk1/2 pathways are involved in the up-regulation of c-myc and cyclin d1 expression mediated by PRL. The previous findings suggest the existence of two PRL-dependent signaling cascades, initiated by the c-Src-mediated activation of Fak/Erk1/2 and PI3K pathways that, subsequently, control the expression of c-Myc and cyclin D1 and the proliferation of T47D and MCF7 breast cancer cells.

10 November 2004 in FEBS Letters
Verified
Journal Article
Closed access
MSMarta Salinas
Marta Salinas
JWJinling Wang
Jinling Wang
MSMaría Rosa de Sagarra
María Rosa de Sagarra
DMDaniel Martín
Daniel Martín
ASAna I Rojo Sanchis
Ana I Rojo Sanchis
Antonio CuadradoaAntonio Cuadradoa
Antonio Cuadradoa

1 July 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LGLorena González
Lorena González
MAM. Teresa Agulló-Ortuño
M. Teresa Agulló-Ortuño
JGJosé Manuel García-Martínez
José Manuel García-Martínez
ACAnnarica Calcabrini
Annarica Calcabrini
CGCarlos Gamallo
Carlos Gamallo
Jorge Martín-PérezJorge Martín-Pérez
Jorge Martín-Pérez
To study the role of c-Src in breast cancer tumorigenesis, we generated a cell line derived from MCF7 carrying an inducible dominant negative c-Src (c-SrcDN: K295M/Y527F) under tetracycline control (Tet-On system). c-SrcDN expression caused phenotypic changes, relocation of c-Src, Fak, and paxillin, and loss of correct actin fiber assembly. These alterations were coupled to increased Fak-Tyr397 autophosphorylation and to inhibition of Fak-Tyr925, p130CAS, and paxillin phosphorylation. An increased association of total Src with Fak and a decreased interaction of p130CAS and p85-PI3K with Fak were also observed. SrcDN inhibited cell attachment, spreading, and migration. Serum and EGF-induced stimulation of cell proliferation and Akt phosphorylation were also significantly reduced by SrcDN, whereas p27Kip1 expression was increased. Consistently, silencing c-Src expression by siRNA in MCF7 cells significantly reduced cell migration, attachment, spreading and proliferation. Inoculation of MCF7 cells carrying inducible SrcDN to nude mice generated tumors. However, doxycycline administration to mice significantly reduced tumorigenesis, and when doxycycline treatment was installed after tumor development, a significant tumor regression was observed. In both situations, inhibition of tumorigenesis was associated with decreased Ki67 staining and increased apoptosis in tumors. These data undoubtedly demonstrate the relevance of the Src/Fak complex in breast cancer tumorigenesis.

1 February 1983 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Jorge Martín-PérezJorge Martín-Pérez
Jorge Martín-Pérez
GTG Thomas
G Thomas
The amino acids and tryptic peptides that become phosphorylated in 40S ribosomal protein S6 after serum stimulation of quiescent [mouse fibroblast] 3T3 cells were examined by 2-dimensional thin-layer electrophoresis. In the maximally phosphorylated form of the protein, most of the phosphate was incorporated into serine and a small amount, into threonine. Digestion of this form of the protein with trypsin revealed 10 major phosphopeptides. All 10 contained phosphoserine and 2 of the 10 also contained phosphothreonine. Next, the 5 forms of increasingly phosphorylated S6 were individually separated on 2-dimensional polyacrylamide gels or total S6 was isolated from cells that were stimulated for only a short time and their phosphotryptic maps were analyzed. The results showed that, as larger amounts of phosphate were added to S6, the phosphopeptides appeared in a specific order.